Chapter 6: Ecological Risk Assessment
Chapter: 6 Ecological Risk Assessment
EcoRA methodology has been developed from that already established for human health. The general principles are widely agreed upon but the application of the process still provokes considerable argument. The Health Risk Assessment (HRA) approach lends itself well in many respects to EcoRA but, due to the complex nature of the potential target(s) or receptor(s), several problems have presented themselves to practitioners. HRA is concerned with individuals and morbidity and mortality, EcoRA is concerned with populations and communities and the effects of substances on mortality and fecundity. EcoRA has to deal with a multitude of organisms, all with varying sensitivities to chemicals and various groups have distinct exposure scenarios, such as free swimmers and sediment dwellers. Because of the difficulty in obtaining toxicity data on all organisms in an ecosystem, the recognised practice is to test selected representatives of major taxonomic groups and use these as surrogates for the whole system. This method is questionable as it may not protect the most sensitive species exposed in the environment. Failure to identify the effects of an agent on a potential receptor can result in widespread damage to organisms and ecosystems. A typical example is the use of anti-fouling paints containing tributyltin and the resulting damaging effect on oysters and dog whelks.
The book describes, in detail, the methodology for ecological risk assessment used in the regulation of new and existing substances in the EU, as described in the EU Technical Guidance Documents as environmental risk assessment.
The method consists of the four steps used in health risk assessment although Hazard Identification and Dose-response Assessment are combined in the single step Effects Assessment:
Similar schemes have been developed by the OECD and others.
Ecological risk assessment is very much a developing field and has many problems which need resolving such as;
Many countries and international bodies have developed their own procedures and guidelines for the risk assessment of plant protection products. A joint panel of the European and Mediterranean Plant Protection Organisation and the Council of Europe have developed a scheme which aims to provide a framework for the evaluation of risks leading to the approval and setting of conditions for use of plant protection products. The scheme is detailed in the book and an example of the risk assessment of Metosulam is provided. Details of the RIVM USES scheme for agricultural pesticides are also provided.
A risk assessment is required by EC Directive 90/220/EEC on 'the deliberate release into the environment of genetically modified organisms' before consent is approved on the marketing or deliberate release of Genetically Modified Organisms (GMOs). Most EU States have developed methodologies for the risk assessment of GMOs and have organisations conducting research to refine the methodologies used to protect man and the environment (details can be found on the Belgian Biosafety Server on the Internet).
At an international level, UNEP has been influential in the establishment of an international agreement on biodiversity, the Convention on Biological Diversity, signed by over 150 nations. This body is now working towards the creation of a Biosafety Protocol to be enacted in 1999. The work includes the evaluation of the existing policies and guidelines of the OECD, the FAO and the International Technical Guidance on Safety in Biotechnology being finalised by UNEP.
In the UK Guidance Document, risk assessment consists of seven steps (risk management is also integrated within the procedure). The book describes the steps and provides an example of the results of an assessment for the genetic modification of oil seed rape.
For references, please go to http://www.eea.europa.eu/publications/GH-07-97-595-EN-C2/chapter6h.html or scan the QR code.
PDF generated on 27 Feb 2017, 06:39 PM